Pharma Equity Group A/S
CSE:PEG

Watchlist Manager
Pharma Equity Group A/S Logo
Pharma Equity Group A/S
CSE:PEG
Watchlist
Price: 0.0972 DKK -2.8% Market Closed
Market Cap: 119.3m DKK

Profitability Summary

Pharma Equity Group A/S's profitability score is 21/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

21/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

21/100
Profitability
Score
21/100
Profitability
Score

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Pharma Equity Group A/S

Revenue
0 DKK
Operating Expenses
-18m DKK
Operating Income
-18m DKK
Other Expenses
-2.8m DKK
Net Income
-20.9m DKK

Margins Comparison
Pharma Equity Group A/S Competitors

Country Company Market Cap Operating
Margin
Net
Margin
DK
Pharma Equity Group A/S
CSE:PEG
119.3m DKK N/A N/A
DE
Vonovia SE
XETRA:VNA
20.4B EUR
39%
54%
HK
Swire Properties Ltd
HKEX:1972
122.1B HKD
50%
-24%
BM
Hongkong Land Holdings Ltd
SGX:H78
15.1B USD
39%
-19%
CN
Zhejiang China Commodities City Group Co Ltd
SSE:600415
91.3B CNY
28%
23%
CN
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
99.4B HKD
27%
21%
IL
Azrieli Group Ltd
TASE:AZRG
39.5B ILS
59%
43%
CH
Swiss Prime Site AG
SIX:SPSN
9.7B CHF
66%
58%
PH
SM Prime Holdings Inc
XPHS:SMPH
640.4B PHP
50%
34%
SG
Capitaland Investment Ltd
SGX:9CI
13.4B SGD
24%
17%
SE
Sagax AB
STO:SAGA A
91.3B SEK
80%
61%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Pharma Equity Group A/S Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DK
Pharma Equity Group A/S
CSE:PEG
119.3m DKK
-64%
-30%
-36%
-26%
DE
Vonovia SE
XETRA:VNA
20.4B EUR
11%
3%
2%
6%
HK
Swire Properties Ltd
HKEX:1972
122.1B HKD
-1%
-1%
2%
4%
BM
Hongkong Land Holdings Ltd
SGX:H78
15.1B USD
-1%
-1%
2%
3%
CN
Zhejiang China Commodities City Group Co Ltd
SSE:600415
91.3B CNY
20%
10%
22%
10%
CN
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
99.4B HKD
23%
12%
24%
24%
IL
Azrieli Group Ltd
TASE:AZRG
39.5B ILS
11%
4%
7%
5%
CH
Swiss Prime Site AG
SIX:SPSN
9.7B CHF
5%
3%
3%
2%
PH
SM Prime Holdings Inc
XPHS:SMPH
640.4B PHP
11%
5%
9%
6%
SG
Capitaland Investment Ltd
SGX:9CI
13.4B SGD
3%
2%
2%
2%
SE
Sagax AB
STO:SAGA A
91.3B SEK
8%
4%
5%
5%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less